scRNAseq of thyroid eye disease orbital fat demonstrates fibroblast thyroid hormone signalling and SPARC production

Introduction Thyroid eye disease (TED) is a debilitating extrathyroidal manifestation of Graves’ disease in which orbital inflammation, extracellular matrix overproduction, and adipose tissue expansion cause proptosis, disfigurement, and sight loss. There remains an unmet need for reliable serum biomarkers of active disease to enable earlier diagnosis and inform treatment decisions. We used single-cell RNA sequencing (scRNAseq) of orbital fat to characterise the pathological landscape of TED, then investigated candidate secreted mediators as circulating biomarkers across multiple independent clinical cohorts. Methods Orbital fat obtained from decompressions in four people with TED was profiled by scRNAseq. In three separate cohorts, serum levels of SPARC, fibronectin, IGF-1, and other serum proteins were measured by ELISA in healthy controls and participants with thyroid disease stratified by TED severity and validated in an independent cohort. Correlations with thyroid function tests (FT3, FT4, and TSH) and longitudinal changes over 48 weeks were also assessed. In additional orbital fat samples, SPARC protein distribution was characterised by immunofluorescence. Results scRNAseq identified orbital fibroblast subsets expressing thyroid hormone receptors (THRA, THRB), the T4/T3 transporter SLC16A2, DIO2, IGF1R, and extracellular matrix proteins including SPARC. Serum SPARC was significantly elevated in people with thyroid disease compared to healthy controls and was highest in those with moderate-to-sight-threatening TED across all three primary cohorts, with validation in an additional cohort. In moderate-to-sight-threatening TED, serum SPARC correlated positively with FT3 and negatively with TSH. SPARC and IGF-1 were positively correlated regardless of TED status. Longitudinal follow-up demonstrated that serum SPARC declined significantly by week 48 as clinical activity scores fell. Immunofluorescence confirmed heterogeneous SPARC expression by fibroblasts in both control and TED orbital fat. Discussion SPARC is highly expressed by orbital fat fibroblasts, its serum levels are elevated in active TED and correlate with both disease severity and thyroid hormone status. These findings suggest SPARC as a promising biomarker of active TED and provide evidence linking circulating T3 to orbital fibrotic processes, further supporting strict thyroid function control in TED management.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-12
DOI
https://doi.org/10.3389/fendo.2026.1892749
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

scRNAseq of thyroid eye disease orbital fat demonstrates fibroblast thyroid hormone signalling and SPARC production

Vickie Lee, C. Cuadros Sánchez, Colin Mark Dayan, Jadwiga Furmaniak et al.
Frontiers in Endocrinology
Ophthalmology and Eye Disorders
article

scRNAseq of thyroid eye disease orbital fat demonstrates fibroblast thyroid hormone signalling and SPARC production

Vickie Lee, C. Cuadros Sánchez, Colin Mark Dayan, Jadwiga Furmaniak, Stephanie Jean Hanna, Kathrine Boest-Bjerg, Ilaria Muller, Anja Katrin Eckstein, Catherine E. Rennie, Liz Palmer, Daniel S. Morris, Sarah J. Richardson, Peter Nicholas Taylor, Robert Andrews, Marian Ludgate, Gina-Eva Görtz, James Alexander Pearson, Emma Robinson, Anjana S. Haridas, Sylvie Agnello, Alexandros Delimichalis, Insa Nolte, Ebony Smith
article en

Abstract

Introduction Thyroid eye disease (TED) is a debilitating extrathyroidal manifestation of Graves’ disease in which orbital inflammation, extracellular matrix overproduction, and adipose tissue expansion cause proptosis, disfigurement, and sight loss. There remains an unmet need for reliable serum biomarkers of active disease to enable earlier diagnosis and inform treatment decisions. We used single-cell RNA sequencing (scRNAseq) of orbital fat to characterise the pathological landscape of TED, then investigated candidate secreted mediators as circulating biomarkers across multiple independent clinical cohorts. Methods Orbital fat obtained from decompressions in four people with TED was profiled by scRNAseq. In three separate cohorts, serum levels of SPARC, fibronectin, IGF-1, and other serum proteins were measured by ELISA in healthy controls and participants with thyroid disease stratified by TED severity and validated in an independent cohort. Correlations with thyroid function tests (FT3, FT4, and TSH) and longitudinal changes over 48 weeks were also assessed. In additional orbital fat samples, SPARC protein distribution was characterised by immunofluorescence. Results scRNAseq identified orbital fibroblast subsets expressing thyroid hormone receptors (THRA, THRB), the T4/T3 transporter SLC16A2, DIO2, IGF1R, and extracellular matrix proteins including SPARC. Serum SPARC was significantly elevated in people with thyroid disease compared to healthy controls and was highest in those with moderate-to-sight-threatening TED across all three primary cohorts, with validation in an additional cohort. In moderate-to-sight-threatening TED, serum SPARC correlated positively with FT3 and negatively with TSH. SPARC and IGF-1 were positively correlated regardless of TED status. Longitudinal follow-up demonstrated that serum SPARC declined significantly by week 48 as clinical activity scores fell. Immunofluorescence confirmed heterogeneous SPARC expression by fibroblasts in both control and TED orbital fat. Discussion SPARC is highly expressed by orbital fat fibroblasts, its serum levels are elevated in active TED and correlate with both disease severity and thyroid hormone status. These findings suggest SPARC as a promising biomarker of active TED and provide evidence linking circulating T3 to orbital fibrotic processes, further supporting strict thyroid function control in TED management.

Frontiers in EndocrinologyVol. 17
Cardiff and Vale University Health Board (GB), Moorfields Eye Hospital NHS Foundation Trust (GB), Imperial College Healthcare NHS Trust (GB), University of Milan (IT), University of Exeter (GB), London North West Healthcare NHS Trust (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Maggiore (IT), Essen University Hospital (DE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Imperial College London (GB), University of Duisburg-Essen (DE), Cardiff University (GB), University of Birmingham (GB)
Good health and well-being
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon